RELATED CATEGORIES

All Categories

Bad Pharma How Drug Companies Mislead Doctors and Harm Patients

Ben Goldacre

Faber & Faber

0865478007

9780865478008

Hardcover

448 Pages

$28.00

Request Exam Copy Request Desk Copy
We like to imagine that medicine is based on evidence and the results of fair testing and clinical trials. In reality, those tests and trials are often profoundly flawed. We like to imagine that doctors who write prescriptions for everything from antidepressants to cancer drugs to heart medication are familiar with the research literature about a drug, when in reality much of the research is hidden from them by drug companies. We like to imagine that doctors are impartially educated, when in reality much of their education is funded by the pharmaceutical industry. We like to imagine that regulators have some code of ethics and let only effective drugs onto the market, when in reality they approve useless drugs, with data on side effects casually withheld from doctors and patients.
 
All these problems have been shielded from public scrutiny because they’re too complex to capture in a sound bite. But Ben Goldacre shows that the true scale of this murderous disaster fully reveals itself only when the details are untangled. He believes we should all be able to understand precisely how data manipulation works and how research misconduct in the medical industry affects us on a global scale.
 
With Goldacre’s characteristic flair and a forensic attention to detail, Bad Pharma reveals a shockingly broken system and calls for regulation. This is the pharmaceutical industry as it has never been seen before.

REVIEWS

Praise for Bad Pharma

In the Press

Bad Pharma | Discourse in Progress
Before we get going, we need to establish one thing beyond any doubt: industry-funded trials are more likely to produce a positive, flattering result than independently funded trials...

Reviews from Goodreads

BACK

BOOK EXCERPTS

Read an Excerpt

1
 

Missing Data
Sponsors get the answer they want
Before we get going, we need to establish one thing beyond any doubt: industry-funded trials are more likely to produce a positive, flattering result than independently funded trials. This is our core premise, and you’re about to read a very short chapter, because this is one of the most well-documented phenomena in the growing field of ‘research about research’. It has also become much easier to study in recent years, because the rules on declaring industry funding have become a little clearer.
We can
Read the full excerpt
BACK

ABOUT THE AUTHOR

  • Ben Goldacre

  • Ben Goldacre
    Ben Goldacre
BACK